Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

Adam Perry shares the story of his journey discussing his diagnosis, treatment and the importance of early detection.

For higher-risk multiple myeloma (MM), successful patient selection and monitoring strategies are vital for the management of adverse events and the disease itself.

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...